Deferoxamine
Deferoxamine Mesylate for Injection, USP
Approved
Approval ID
d91e16df-8daa-4cd2-86a2-273eaa2446e0
Product Type
HUMAN PRESCRIPTION DRUG LABEL
Effective Date
Jan 22, 2020
Manufacturers
FDA
Fresenius Kabi USA, LLC
DUNS: 608775388
Products 2
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
DEFEROXAMINE MESYLATE
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
NDC Product Code63323-597
Application NumberANDA078718
Product Classification
M
Marketing Category
C73584
G
Generic Name
DEFEROXAMINE MESYLATE
Product Specifications
Route of AdministrationINTRAVENOUS, INTRAMUSCULAR, SUBCUTANEOUS
Effective DateMay 16, 2017
FDA Product Classification
INGREDIENTS (1)
DEFEROXAMINE MESYLATEActive
Quantity: 95 mg in 1 mL
Code: V9TKO7EO6K
Classification: ACTIB
DEFEROXAMINE MESYLATE
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
NDC Product Code63323-599
Application NumberANDA078718
Product Classification
M
Marketing Category
C73584
G
Generic Name
DEFEROXAMINE MESYLATE
Product Specifications
Route of AdministrationINTRAVENOUS, INTRAMUSCULAR, SUBCUTANEOUS
Effective DateMay 16, 2017
FDA Product Classification
INGREDIENTS (1)
DEFEROXAMINE MESYLATEActive
Quantity: 95 mg in 1 mL
Code: V9TKO7EO6K
Classification: ACTIB